Beauty Health (SKIN) Projected to Post Quarterly Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is expected to be announcing its Q4 2025 results after the market closes on Thursday, March 12th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $78.0650 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 12, 2026 at 4:30 PM ET.

Beauty Health Stock Performance

Shares of SKIN opened at $1.10 on Thursday. The company has a market cap of $140.25 million, a price-to-earnings ratio of -5.00 and a beta of 1.20. The business’s fifty day simple moving average is $1.31 and its two-hundred day simple moving average is $1.56. Beauty Health has a 12 month low of $0.78 and a 12 month high of $2.69. The company has a current ratio of 4.98, a quick ratio of 4.07 and a debt-to-equity ratio of 5.53.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on SKIN shares. Jefferies Financial Group reaffirmed a “hold” rating and set a $1.60 price objective on shares of Beauty Health in a research report on Wednesday, January 14th. TD Cowen upped their target price on shares of Beauty Health from $1.50 to $1.65 and gave the company a “hold” rating in a research note on Wednesday, January 21st. Zacks Research downgraded shares of Beauty Health from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 21st. Finally, Wall Street Zen lowered shares of Beauty Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Reduce” and an average price target of $2.40.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of SKIN. Invesco Ltd. increased its stake in shares of Beauty Health by 6.6% in the 2nd quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock worth $188,000 after purchasing an additional 6,059 shares in the last quarter. Rhumbline Advisers grew its holdings in Beauty Health by 5.7% during the third quarter. Rhumbline Advisers now owns 150,124 shares of the company’s stock valued at $299,000 after purchasing an additional 8,142 shares during the period. The Manufacturers Life Insurance Company increased its position in Beauty Health by 33.5% in the second quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock worth $79,000 after buying an additional 10,410 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of Beauty Health in the third quarter worth about $26,000. Finally, Franklin Resources Inc. bought a new position in shares of Beauty Health in the third quarter worth about $31,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.